Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Take a Survey on the use of Breathwork
for Anxiety, Depression, Trauma, or PTSD
Researchers at Johns Hopkins seek responses to an anonymous survey on breathwork. You can participate whether your breathwork experiences helped or not.
(Must be 18+) Take the Survey!
MBDB Journal Articles & Abstracts

Drug Testing


Deaths Associated with MBDB Misuse,
by N. Carter; G.N. Rutty; C.M. Milroy; A.R.W. Forrest
Int. J. Legal Med. Vol 113; 2000, 68-170
[ View Reference ]

Derivatives of 1-(1,3-Benzodioxol-5-yl-2-butanamine: Representatives of a Novel Therapeutic Class,
by D.E. Nichols; A.J. Hoffman; R.A. Oberlender; P. Jacob III; A.T. Shulgin
J. Med. Chem Vol 29; 1986, 2009-2015

Hallucinogenic and Stimulatory Amphetamine Derivatives: Fingerprinting DOM, DOI, DOB, MDMA, and MBDB by Spectral Analysis of Brain Field Potentials in the Freely Moving Rat (Tele-Stereo-EEG),
by W. Dimpfel; M. Sp¸ler, and D.E. Nichols
Psychopharmacology Vol 98; 1989, 297-303
[ View Reference ]

Microdialysis Studies on 3,4-Methylenedioxyamphetamine and Structurally Related Analogues,
by J.F. Nash; D.E. Nichols
Europ. J. Pharmacol Vol 200; 1991, 53-58
[ View Reference ]

(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a Discriminative Stimulus in Studies of 3,4-methylenedioxymethamphetamine-Like Behavioural Activity,
by R. Oberlender; D.E. Nichols
J. Pharm. Exptl. Therap Vol 225; 1990, 1098-1106
[ View Reference ]

Reinforcing Effects of Certain Serotonin-Releasing Amphetamine Derivatives,
by D. Marona-Lewicka; G.S. Rhee; J.E. Sprague; D.E. Nichols
Pharmacol Biochem Behav Vol 53 (No 1) Jan 1996, 99-105
[ View Reference ]



Differences Between the Mechanism of Action of MDMA, MBDB and the Classic Hallucinogens,
by D. Nichols
Journal of Psychoactive Drugs Vol 18 (No 4) 1986
[ View Reference ]

The Effects of MDMA and Other Methylenedioxy-substituted Phenylalkylamines on the Structure of Rat Locomotor Activity,
by M.P. Paulus; M.A. Geyer
Neuropsychopharm Vol 7; 1992, 15-31
[ View Reference ]

Excretion of MBDB and BDB in Urine, Saliva, and Sweat Following Single Oral Administration,
by P. Kintz
Journal of Analytical Toxicology Vol 21 (No 7) Nov/Dec 1997, 570–575

The Neuroendocrine Pharmacology of Three Serotonin Releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAI) and p-methylthioamphetamine (MTA),
by Q. Li, I. Murakami, S. Stall, A.D. Levy, M.S. Brownfield, D.E. Nichols, and L.D. Van de Kar
J. Pharmacol. Exp. Ther. Vol 279; 1996, 1261-1267



Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users,
by R Kronstrand
J Anal Toxicol Vol 20 (No 6) 1996, 512-6
[ View Reference ]